These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library. Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933 [TBL] [Abstract][Full Text] [Related]
7. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma. Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831 [TBL] [Abstract][Full Text] [Related]
8. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology. El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847 [TBL] [Abstract][Full Text] [Related]
9. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis. Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies. Khattab SN; Hassan SY; Bekhit AA; El Massry AM; Langer V; Amer A Eur J Med Chem; 2010 Oct; 45(10):4479-89. PubMed ID: 20708306 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Hassan SY; Khattab SN; Bekhit AA; Amer A Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors. El-Adl K; El-Helby AA; Sakr H; Elwan A Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors. Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors. Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739 [TBL] [Abstract][Full Text] [Related]
15. Exploring new selective 3-benzylquinoxaline-based MAO-A inhibitors: design, synthesis, biological evaluation and docking studies. Khattab SN; Abdel Moneim SA; Bekhit AA; El Massry AM; Hassan SY; El-Faham A; Ali Ahmed HE; Amer A Eur J Med Chem; 2015 Mar; 93():308-20. PubMed ID: 25707011 [TBL] [Abstract][Full Text] [Related]
16. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Abbass EM; Khalil AK; Mohamed MM; Eissa IH; El-Naggar AM Bioorg Chem; 2020 Nov; 104():104255. PubMed ID: 32927130 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site. Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902 [TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967 [TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors. Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors. Chen C; Yang X; Fang H; Hou X Eur J Med Chem; 2019 Nov; 181():111563. PubMed ID: 31415980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]